In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: PPL's current price exceeds its PERT-weighted fair value by 31.3%, indicating potential overvaluation based on conservative DCF and P/E estimates despite higher EV/EBITDA and analyst targets. Poor financial health scores and a high Monte Carlo downside risk of 97.2% highlight significant investment risk. Valuation volatility signals uncertainty in growth and profitability prospects.